CLINICAL_TRIALS
trial_result
· 2012-05-01
Clinical Trial Update: S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 2]
Summary
Phase 2 trial evaluating cetuximab in metastatic esophageal cancer or gastroesophageal junction cancer has completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SWOG Cancer Research Network | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-05-01